The healthcare industry is witnessing significant advancements in fibrotic disease therapies, rare disease therapeutics, and immunosuppressive therapy as researchers focus on developing targeted treatments for complex chronic conditions. Fibrosis-related disorders, autoimmune diseases, and rare immune-mediated conditions represent major therapeutic challenges due to their...